Good MorningEquity markets rebounded on Wednesday to add about 1.5% to the S&P 500. The driver was better than expected earnings from Nike that have enriched hopes that Q4 earnings reporting season won't be as bad as feared. As it is, the market is expecting about a 2.5% decline in S&P 500 earnings and the consensus is falling. The takeaway for investors is that results may be enough to keep the bulls interested and the S&P 500 bobbing sideways within its current range.
The big news this week will come out tomorrow with the PCE price index. The index is expected to subside on a YOY basis at the core level which is what the market needs to see. If the index confirms expectations there is a very good chance Santa Clause will bring a rally next week. Featured: Laser Breakthrough Could Send This Stock Soaring (Behind the Markets) 
|
Markets | | |
Viking Therapeutics (NASDAQ: VKTX) develops novel therapeutics for patients suffering from disorders related to the metabolic and endocrine systems. Recently, their stock soared for a somewhat unique reason: the success of a peer. While they can certainly develop their own promising products, thei... Read the Full Story |
|
From Our PartnersI'm not recommending any giant companies here...
I prefer recommending biotechs on the very forefront of massive change.
That's where all the innovation is... and the best potential for investors. | | Click here to see my biggest recommendation ever. |
|
Stocks | | |
As temperatures drop throughout the U.S., sunshine and warmth may seem like distant dreams. But for shareholders of top-performing solar-energy stocks such as Enphase Energy Inc. (NASDAQ: ENPH), SolarEdge Technologies Inc. (NASDAQ: SEDG), and First Solar Inc. (NASDAQ: FSLR), those brighter days ma... Read the Full Story |
|
Markets | | |
Shares of Fedex Corporation (NYSE: FDX) are up over 5% the day after the company surprised investors with a beat on the bottom line. The $3.18 earnings per share (EPS) the company delivered was over 12% higher than analysts’ expectations for EPS of $2.82.
That’s the good news. T... Read the Full Story |
|
From Our PartnersOn October 27, the CEO of New England's largest energy company sent a desperate letter to the White House.
"This represents a serious public health and safety threat," Eversource CEO Joe Nolan wrote in a letter to President Joe Biden.
He then begged Biden to use the federal government's emergency powers to make sure natural gas will be available in New England this winter. | | | | Just click here and watch their video |
|
Markets | | | Shares are higher in Asia after a rally on Wall Street as investors welcomed a report showing U.S. consumer confidence is holding up despite the Federal Reserve's campaign to fight inflation by raising interest rates Read the Full Story |
|
Stocks | | | Stocks closed broadly higher on Wall Street Wednesday and pushed major indexes into the green for the week, as investors welcomed a report showing consumer confidence is holding up better than expected.
The S&P 500 and Nasdaq composite each rose 1.5%. The Dow Jones Industrial Ave... Read the Full Story |
|
From Our PartnersTwo unelected billionaires who exist outside the checks and balances of Washington D.C, yet wield far more power than any political party.
And what they have planned next will terrify you…
It could result in tens of millions of Americans being wiped out financially. | | | | Just click here and watch their video |
|
Markets | | |
On a day when the broader market soared over 500 points, Lucid Group, Inc. (NASDAQ: LCID) was a notable laggard. Shares of LCID stock fell by less than one percent. But it continues the downward trend for the stock, down 30% in the last month and over 80% in 2022.
One sore spot for investor... Read the Full Story |
|
Markets | | | World shares are mixed after a rally on Wall Street as investors welcomed a report showing U.S. consumer confidence is holding up despite the Federal Reserve's campaign to fight inflation by raising interest rates Read the Full Story |
|
Markets | | | World shares are mixed after a rally on Wall Street as investors welcomed a report showing U.S. consumer confidence is holding up despite the Federal Reserve's campaign to fight inflation by raising interest rates Read the Full Story |
|
Markets | | |
NIKE, Inc. (NYSE: NKE) stock is set up for a reversal, and the 2023 outlook may drive it. The company just reported earnings for CQ4 and not only beat on the top and bottom lines but showed significant improvement in its inventory position. This is important because bloating inventories and the ne... Read the Full Story |
|
Tech | | | Nikiesha Barnett had knee surgery in 2006 and took unpaid leave from her job as a Georgia hospital coordinator while she was recovering. When Barnett wasn’t able to keep up with the payments for the surgery, she ended up owing about $4,500.
That debt lingered for almost 14 years until... Read the Full Story |
|
Thursday's Early Bird Stock Of The Day Portage Biotech Inc., a clinical stage immune-oncology company, engages in the research and develops pharmaceutical and biotechnology products. Its product pipeline includes PORT-2 for treatment of refractory NSCLC, melanoma, and refractory melanoma that is in phase I and phase II clinical trials; PORT-3, for treatment of solid tumors, which is in phase I clinical trials; PORT-6, an A2AR inhibitor to treat A2A & A2B high solid tumors that is in phase Ia clinical trials; PORT-7, an A2AR inhibitor to treat A2A & A2B high solid tumors that is in phase Ib clinical trials; PORT-1, an intratumoral amphiphilic solutions for treatment of advanced soft tissue sarcoma, which is in phase 3 clinical trials; PORT-4, a nanolipogel co-formulations to treat of solid tumors that is in preclinical trials; and PORT-5, a VLP-STING to treat of solid tumors that is in preclinical trials. The company is based in Tortola, British Virgin Islands. | | View Today's Stock Pick |
|
